GT201400115A - Combinación farmacéutica antineurítica y composición - Google Patents
Combinación farmacéutica antineurítica y composiciónInfo
- Publication number
- GT201400115A GT201400115A GT201400115A GT201400115A GT201400115A GT 201400115 A GT201400115 A GT 201400115A GT 201400115 A GT201400115 A GT 201400115A GT 201400115 A GT201400115 A GT 201400115A GT 201400115 A GT201400115 A GT 201400115A
- Authority
- GT
- Guatemala
- Prior art keywords
- antineurítica
- composición
- pharmaceutical combination
- combinations
- pharmaceutical
- Prior art date
Links
- 229940088594 vitamin Drugs 0.000 abstract 2
- 229930003231 vitamin Natural products 0.000 abstract 2
- 235000013343 vitamin Nutrition 0.000 abstract 2
- 239000011782 vitamin Substances 0.000 abstract 2
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMBINACIONES FARMACÉUTICAS DE DOS ANTIEPILÉPTICOS, ASÍ COMO COMBINACIONES DE UN ANTIEPILÉPTICO, Y VITAMINAS DEL COMPLEJO B, EN DONDE LOS ANTIEPILÉPTICOS SE SELECCIONAN DE PREGABALINA Y OXCARBAZEPINA, Y LAS VITAMINAS SE SELECCIONAN DE VITAMINA B1 Y VITAMINA B12. TAMBIÉN SE REFIERE A COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN DICHAS COMBINACIONES Y AL USO DE DICHAS COMPOSICIONES PARA EL TRATAMIENTO DEL DOLOR NEUROPÁTICO (DN).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2011014042A MX336979B (es) | 2011-12-16 | 2011-12-16 | Combinacion farmaceutica antineuritica y composiciones. |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201400115A true GT201400115A (es) | 2017-07-27 |
Family
ID=48611941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201400115A GT201400115A (es) | 2011-12-16 | 2014-06-16 | Combinación farmacéutica antineurítica y composición |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140323428A1 (es) |
BR (1) | BR112014014774A2 (es) |
CA (1) | CA2859487C (es) |
CL (1) | CL2014001581A1 (es) |
CO (1) | CO6990712A2 (es) |
CR (1) | CR20140283A (es) |
DO (1) | DOP2014000134A (es) |
ES (1) | ES2525952B1 (es) |
GT (1) | GT201400115A (es) |
MX (1) | MX336979B (es) |
NI (1) | NI201400058A (es) |
PE (1) | PE20141688A1 (es) |
PL (1) | PL231163B1 (es) |
WO (1) | WO2013088410A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2826470B1 (en) * | 2013-07-19 | 2017-09-06 | Arven Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of pregabalin |
MX2014008336A (es) | 2014-07-07 | 2016-01-07 | Pptm Internat S A R L | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2006127475A (ru) * | 2003-12-29 | 2008-02-10 | Джейсон МАКДЭВИТТ (US) | Композиции и способы лечения рецидивирующих медицинских состояний |
JP5452494B2 (ja) * | 2007-10-09 | 2014-03-26 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | ベンフォチアミンと1または2種以上の医薬活性剤とを含む神経因性の疼痛状態の処置のための医薬組成物 |
US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
-
2011
- 2011-12-16 MX MX2011014042A patent/MX336979B/es active IP Right Grant
-
2012
- 2012-12-14 CA CA2859487A patent/CA2859487C/en active Active
- 2012-12-14 BR BR112014014774A patent/BR112014014774A2/pt not_active Application Discontinuation
- 2012-12-14 PL PL409542A patent/PL231163B1/pl unknown
- 2012-12-14 US US14/365,988 patent/US20140323428A1/en not_active Abandoned
- 2012-12-14 ES ES201490063A patent/ES2525952B1/es not_active Expired - Fee Related
- 2012-12-14 WO PCT/IB2012/057345 patent/WO2013088410A1/es active Application Filing
- 2012-12-14 PE PE2014000973A patent/PE20141688A1/es active IP Right Grant
-
2014
- 2014-06-16 GT GT201400115A patent/GT201400115A/es unknown
- 2014-06-16 CR CR20140283A patent/CR20140283A/es unknown
- 2014-06-16 DO DO2014000134A patent/DOP2014000134A/es unknown
- 2014-06-16 CO CO14129791A patent/CO6990712A2/es unknown
- 2014-06-16 NI NI201400058A patent/NI201400058A/es unknown
- 2014-06-16 CL CL2014001581A patent/CL2014001581A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20140323428A1 (en) | 2014-10-30 |
MX336979B (es) | 2016-02-09 |
BR112014014774A2 (pt) | 2017-06-13 |
DOP2014000134A (es) | 2014-07-31 |
CL2014001581A1 (es) | 2014-09-26 |
WO2013088410A1 (es) | 2013-06-20 |
PL231163B1 (pl) | 2019-01-31 |
NI201400058A (es) | 2014-12-22 |
CO6990712A2 (es) | 2014-07-10 |
ES2525952B1 (es) | 2015-10-05 |
CR20140283A (es) | 2015-03-11 |
CA2859487C (en) | 2016-11-15 |
CA2859487A1 (en) | 2013-06-20 |
ES2525952A1 (es) | 2015-01-02 |
PE20141688A1 (es) | 2014-12-03 |
PL409542A1 (pl) | 2015-07-20 |
MX2011014042A (es) | 2013-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122786T1 (el) | Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης | |
CR20150326A (es) | Inhibidores de autotaxina | |
GT201700189A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
SV2018005687A (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer | |
CL2013001338A1 (es) | Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih. | |
CL2014001829A1 (es) | Compuestos derivados de indolizina; procedimiento de preparación; composiciones farmacéuticas que los contienen y uso en el tratamiento del cancer. | |
CL2015001437A1 (es) | Derivados de pirimidin-2,4-diamina para el tratamiento de cancer | |
CL2014001793A1 (es) | Compuestos derivados de 1,3,5-triazinas sustituidas y sus sales, como inhibidores de la idh2 mutante; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer. | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
CL2016000063A1 (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
DOP2018000062A (es) | Piridinona dicaboxamidas para uso como inhibidores de bromodominio | |
DOP2016000253A (es) | Nuevos compuestos | |
BR112016028845A2 (pt) | composto, composição farmacêutica e uso de um composto | |
CO2019012767A2 (es) | Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
CL2017002170A1 (es) | Desacetoxitubulisina h y análogos de esta. | |
CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
SV2017005412A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
ECSP14014778A (es) | Composiciones derivadas de la quitosana | |
DOP2015000005A (es) | Derivados de estra 1,3,5(10), 16 tetraeno 3 sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos | |
DOP2016000212A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados | |
SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
BR112017022158A2 (pt) | compostos, composições farmacêuticas e uso de um composto | |
CL2017000587A1 (es) | Derivados de tetrahidroquinolina como inhibidores de bromodominio | |
PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel |